BDK-IN-1 (compound (-)-43) is a BDK inhibitor with an IC50 of 0.23 µM and a maximum inhibition rate of 90%. It reduces phosphorylated-E1 levels and is useful in the study of cardiac metabolic diseases.
Molecular Weight:
376.38
Formula:
C18H14F2N2O3S
Target:
Endogenous Metabolite
* VAT and and shipping costs not included. Errors and price changes excepted
